Gå direkt till huvudinnehållet

Onkologiska akutsituationer

Senast uppdaterad: Senast reviderad:
Sakkunnig:
  1. Higdon ML, Atkinson CJ, Lawrence KV. Oncologic Emergencies: Recognition and Initial Management. Am Fam Phys 2018; 97: 741-48. pmid:30215936 PubMed  
  2. Zagzag J, Hu MI, Fisher SB et al. Hypercalcemia and Cancer: Differential Diagnosis and Treatment. CA Cancer J Clin 2018; 68: 377.86. pmid:30240520 PubMed  
  3. Dickens LT, Derman B, Alexander JT. Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncol. 2023 Jan 13. Epub ahead of print. PMID: 36637830.
  4. Tazmini K, Eriksen EF, Lima K. Nasjonal Veileder i Endokrinologi. Hyperkalsemi. Norsk endokrinologisk forening. Publisert 16.11.2016 www.endokrinologi.no  
  5. Grant P, Ayuk J, Bouloux PM et al. The Diagnosis and Management of Inpatient Hyponatraemia and SIADH. Eur J Clin Invest 2015; 45: 888-94. pmid:25995119 PubMed  
  6. Nationellt vårdprogram akut onkologi. RCC, hämtad 2021-05-24 cancercentrum.se  
  7. Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 1998; 41(suppl D): 65-80.
  8. Helsedirektoratet. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Febril nøytropeni. Helsedirektoratet; 2018. Sist oppdatert 08.01.2018. Sitert 04.05.2018
  9. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992; 10: 316-22. PubMed  
  10. Orala antibiotika kan förenkla behandling för många cancerpatienter med neutropen feber. SBU-kommentar (2014-10-07). www.sbu.se  
  11. Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic Emergencies: Pathophysiology, Presentation, Diagnosis, and Treatment. CA Cancer J Clin 2011; 61: 287-314. pmid:21858793 PubMed  
  12. Gertz MA. Acute hyperviscosity: syndromes and management. Blood 2018; 132: 1379-85. pmid:30104220 PubMed  
  13. Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av lungekreft, mesoteliom og thymom, 2019. www.helsebiblioteket.no  
  14. Drews RE, Rabkin DJ. Malignancy-related superior vena cava syndrome. UpToDate, last updated May 05, 2018. UpToDate  
  15. Al Qurainy R, Collis E. Metastatic spinal cord compression: diagnosis and management. BMJ 2016; 353: i2539. pmid:27199232 PubMed  
  16. Adler Y, Charron P, Imazio M et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Eur Heart J 2015; 36: 2921-64. pmid:26320112 PubMed  
  17. Thandra K, Salah Z, Chawla S. Oncologic Emergencies-The Old, the New, and the Deadly. J Intensive Care Med. 2020 Jan;35(1):3-13. Epub 2018 Nov 9. PMID: 30411648 PubMed  
  18. Mudambi L, Miller R, Eapen GA et al. Malignant Central Airway Obstruction. J Thorac Dis 2017; 9: 1087-110. pmid:29214067 PubMed  
  19. Folch E, Keyes C. Airway stents. Ann Cardiothorac Surg 2018; 7: 273-83. pmid:29707506 PubMed  
  20. Giglio P, Gilbert MR. Neurologic Complications of Cancer and Its Treatment. Curr Oncol Rep 2010; 12: 50-9. pmid:20425608 PubMed  
  21. Krimsky WS, Behrens RJ, Kerkvliet GJ. Oncologic emergencies for the internist. Cleve Clin J Med 2002; 69: 209-10. PubMed  
  22. Cervantes A, Chirivella I. Oncologic emergencies. Ann Oncol 2004; 15: 299-306. PMID: 15477325 PubMed  
  23. Kroschinsky F, Stölzel F, Bonin S et al. New Drugs, New Toxicities: Severe Side Effects of Modern Targeted and Immunotherapy of Cancer and Their Management. Crit Care 2017; 21: 89. pmid:28407743 PubMed  
  24. Brahmer JR, Lacchetti C, Thompson JA. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract 2018; 14: 247-49. pmid:29517954 PubMed  
  • Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet

Tidigare sakkunniga

  • Maria Albertsson Professor och överläkare, Onkologiska kliniken, Universitetssjukhuset Linköping
  • Silje Folven Barlindhaug, spesialist i allmennmedisin, redaktør NEL